Surgical Robots Are Advancing, but Where do they Add Value?

HealthSpark, Episode 32: Ali Tavakkoli, chief of the Division of General and GI Surgery at Mass General Brigham and Francis D. Moore Professor of Surgery at Harvard Medical School, examines the rapid increase in robotic surgery and why careful evaluation will decide where these technologies improve care and for whom.

Ali HealthSpark

Medical Device Development graphic

What makes an innovation valuable?

Some medical devices or technologies can make previously difficult or invasive procedures possible. Others may make an established procedure somewhat easier to perform without significantly improving outcomes--and may even add cost when an effective, less expensive alternative already exists. A medical innovation delivers meaningful value when it addresses a specific clinical need and produces measurable benefits, such as better outcomes or fewer complications that justify its cost to health care organizations, payers, and patients.

When does an innovation's promise become evidence?

Market interest and competition do not demonstrate that a technology improves care. As new robotic platforms and medical innovations enter surgical practice, decision-makers need well-designed studies to compare them with existing approaches and understand how they perform, where they are most useful, and who benefits most. Ongoing monitoring and real-world data can also help demonstrate whether a medical innovation is safe, effective, worth its cost, and suited to the care settings where it is used.

Can partnerships achieve what competition can't?

The emergence of multiple robotic platforms can encourage innovation, offer hospitals different capabilities, and put pressure on prices. But manufacturers and health systems also need to collaborate to evaluate these platforms in practice. By tracking use, outcomes, costs, and complications, and sharing relevant findings, they can determine which features improve care, which patient groups benefit, and which procedures are most appropriate for robotic assistance. This evidence can guide product improvements and clarify where robotic surgery should, and should not, become part of routine care.

Key question to take forward:

As you watch the video and consider your own setting, you might reflect on: 

What evidence and perspectives should guide decisions regarding the adoption of an emerging technology?

 

Sign Up to Receive HealthSpark Weekly

 

SLP Course Strip

Explore Related Programs:

To explore how emerging technologies such as robotic surgical platforms and other medical devices progress from innovation to adoption, check out the Medical Device Development and Commercialization course in HealthXcelerate. Ali Tavakkoli also co-leads the Surgical Leadership Program, a certificate program for surgeons that builds nontechnical skills such as communication, change management, quality improvement, financial management, and innovation.

Medical Device Development and Commercialization

Examine the structure of the medical device industry, including the major types of devices on the market today, how companies are typically organized, their economics, and the keys to success in the industry.

  • HealthXcelerate
  • Online; Self-Paced
  • Group Enrollment Option
  • Start Today

Dates: Always Available

For: Health care professionals throughout the industry seeking better understanding of the health care system

Surgical Leadership

Designed by surgeons, for surgeons. Develop essential executive and leadership skills to drive change in surgery and lead surgical teams, departments, and institutions through this comprehensive certificate program.

  • Postgraduate Certificate
  • Blended

Dates: -

For: Surgeons who currently hold or seek to attain a leadership position, including leadership of departments, divisions, large organizations, programs, and new initiatives